ERNEST HAWK to Cyclooxygenase 2
This is a "connection" page, showing publications ERNEST HAWK has written about Cyclooxygenase 2.
Connection Strength
0.337
-
Cyclooxygenase inhibition in cancer prevention and treatment. Expert Opin Pharmacother. 2003 Dec; 4(12):2193-204.
Score: 0.048
-
Development of COX inhibitors in cancer prevention and therapy. Am J Clin Oncol. 2003 Aug; 26(4):S48-57.
Score: 0.047
-
Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials. Prog Exp Tumor Res. 2003; 37:210-42.
Score: 0.045
-
COX-2 in cancer--a player that's defining the rules. J Natl Cancer Inst. 2002 Apr 17; 94(8):545-6.
Score: 0.043
-
The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des. 2002; 8(12):1035-62.
Score: 0.042
-
The future of colon cancer prevention. Ann N Y Acad Sci. 2001 Dec; 952:88-108.
Score: 0.041
-
Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev. 2017 06; 36(2):289-303.
Score: 0.030
-
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst. 2007 Apr 04; 99(7):545-57.
Score: 0.015
-
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000 Jun 29; 342(26):1946-52.
Score: 0.009
-
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res. 2000 Apr 01; 60(7):1864-70.
Score: 0.009
-
Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis. 1999 Feb; 20(2):185-91.
Score: 0.009